期刊文献+

喷射心肌打孔填充不同凝胶支架后心肌孔道演变规律的实验研究 被引量:1

Changes of transmyocardial channels filled with different hydrogel scaffolds after transmyocardial jet revascularization in dogs
原文传递
导出
摘要 目的观察喷射心肌打孔填充不同凝胶支架后犬心肌孔道的演变规律以及不同凝胶支架在心肌组织中的组织相容性。方法 12只健康杂种犬,体质量9~13kg,年龄1~2岁,均分为琼脂糖凝胶(agarose hydrogel,AH)组、纤维蛋白凝胶(fibrin glue,FG)组、壳聚糖凝胶(chitosan hydrogel,CH)组,每组4只。各组用无针注射器分别喷射各种凝胶心肌打孔,于术后2、4、6周取含有孔道的心肌组织行HE、Masson染色,观察各种凝胶支架在心肌组织中的降解性和组织相容性,以及各组心肌孔道是否保留和开放。结果纤维蛋白凝胶2周内绝大部分已经降解,引起较少的炎性反应和胶原纤维增生,降解后心肌孔道闭塞,同时心内膜面发现附壁血栓形成;琼脂糖凝胶6周时仍有较多凝胶未降解,引起周围组织大量胶原增生,心肌孔道完全闭塞;壳聚糖凝胶的降解周期为4~6周,降解后可见心肌孔道开放及孔道壁内皮化。结论琼脂糖凝胶和纤维蛋白凝胶均不适合作为心肌孔道支架,而壳聚糖凝胶是一种良好的心肌孔道支架。 Objective To investigate the changes of transmyocardial channels after being filled with different hydrogel scaffolds by transmyocardial jet revascularization (TMJR) in dogs and the histocompatibility of different hydrogel scaffolds in myocardium. Methods Twelve healthy mongrel dogs,with body weight 9 to 13 kg,aged 1 to 2,were randomly divided into 3 groups,agarose hydrogel group (AH group),fibrin glue group (FG group) and chitosan hydrogel group (CH group),4 animals in each group. Transmyocardial revascularization in different groups was performed with needle-free systems to jet out different hydrogels. Samples of myocadial tissues of 3 groups were obtained at 2,4,and 6 weeks after operation for hematoxylin-eosin (HE) staining and Masson staining to observe the degradation and histocompatibility of the 3 hydrogels in the myocardium and whether the channels in 3 groups could keep patency. Results Fibrin glue had been degraded mostly in less than 2 weeks with less inflammatory response and collagen fibers. The channels in this group were almost occluded after degradation. Moreover mural thrombus was found on the endocardial surface. There were much undegraded agarose hydrogel at 6 weeks,with the collagen fibers proliferating in surrounding tissue and the channels being occluded completely. The degradation cycle of chitosan hydrogel was observed at 4 to 6 weeks and the channels kept patency and endothelialization after degradation. Conclusion Agarose hydrogel and fibrin glue are not suitable for transmyocardial channel scaffolds,while chitosan hydrogel is a good substance for preparing transmyocardial channels scaffolds.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第12期1282-1285,共4页 Journal of Third Military Medical University
基金 国家自然科学基金重点项目(30527001) 国家自然科学基面上项目(30670870) 重庆市科技攻关重点项目(CSTC2005AA5008-5)~~
关键词 心肌 注射 喷射 凝胶类 支架 myocardium injections jet gels stents dogs
  • 相关文献

参考文献17

  • 1Tasse J, Arora R. Transmyocardial revascularization: peril and potential[J]. J Cardiovasc Pharmacol Ther, 2007, 12 ( 1 ) : 44 - 53.
  • 2Lu W N, Lu S H, Wang H B, et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel [ J]. Tissue Eng Part A, 2009, 15 (6) : 1437 - 1447.
  • 3Allen K B, Kelly J, Borkon A M, et al. Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions [ J ]. Anesthesiol Clin, 2008, 26(3): 501 -519.
  • 4赵健,王颖,刘晓程.激光、机械心肌打孔血运重建机制的探讨及比较[J].心血管病学进展,2007,28(6):927-930. 被引量:4
  • 5Briones E, Lacalle J R, Marin I. Transmyocardial laser revascularization versus medical therapy for refractory angina [ J ]. Cochrane Database Syst Rev, 2009, (1) : CD003712.
  • 6Horvath K A. Transmyocardial laser revascularization [ J ]. J Card Surg, 2008, 23 (3) : 266 - 276.
  • 7李长青,周跃.椎间盘组织工程支架材料研究进展[J].中国修复重建外科杂志,2005,19(12):1033-1035. 被引量:4
  • 8王伟,范明,智小东,刘淑红,刘品端.神经支架复合体修复周围神经缺损[J].中国医学科学院学报,2005,27(6):688-691. 被引量:12
  • 9Bensaid W, Triffitt J T, Blanchat C, et al. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation [ J]. Biomaterials, 2003, 24 (14) : 2497 - 2502.
  • 10Yu J, Christman K L, Chin E, et al. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy[ J]. J Thorac Cardiovasc Surg, 2009, 137(1) : 180-187.

二级参考文献67

  • 1李强,李民,伍亚民.雪旺氏细胞促进周围神经再生的分子机制[J].中华物理医学与康复杂志,2004,26(9):561-563. 被引量:8
  • 2谢勇,周南进,谢正兴,熊水印,陈江,吕农华,王崇文.壳聚糖体内外抗幽门螺杆菌的实验研究[J].中华微生物学和免疫学杂志,2006,26(3):193-198. 被引量:5
  • 3Mohammad J,Shenaq J,Rabinovsky E,et al.Modulation of peripheral nerve regeneration:a tissue-engineering approach.The role of amnion tube nerve conduct across a 1-centimeter nerve gap.Plast Reconstr Surg,2000,105(2):660-666
  • 4Schicho R,Skofitsch G,Donnerer J.Regenerative effect of human recombinant NGF on capsaicin-lesioned sensory neurons in the adult rat.Brain Res,1999,815(1):60-69
  • 5Toba T,Nakamura T.Regeneration of canine peroneal nerve with the use of a polyglycolic acid-collagen tube filled with laminin-soaked collagen sponge:a comparative study of collagen sponge and collagen fibers as filling materials for nerve conducts.J Biomed Mater Res,2001,58(6):622-630
  • 6Evans GR,Brandt K,Katz S,et al.Bioactive poly (L-lactic acid) conducs seeded with Schwann cells for peripheral nerve regeneration.Biomaterials,2002,23(3):841-848
  • 7Balgude AP,Yu X,Szymanski A,et al.Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures.Plast Reconstr Surg,2001,107(2):485-496
  • 8Andersson GB. Epidemiologic aspects on low-back pain in industry. Spine, 1981, 6(1): 53-60.
  • 9Risbud MV, Albert TJ,Guttapalli A, et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy.Spine,2004,29(23):2627-2632.
  • 10Setton LA, Chen J. Cell mechanics and mechanobiology in the intervertebral disc.Spine,2004,29(23):2710-2723.

共引文献43

同被引文献22

  • 1Roger VL, Go AS, Lloyd-Jones DM. Heart disease and stroke statistics--2011 update: a report from the American Heart Association [J]. Circulation, 2011, 123 (4): e 18-e209.
  • 2Li SC, Wang L, Jiang H, et al. Stem cell engineering for treatment of heart diseases: potentials and challenges[J]. Cell Biol Int, 2009, 33(3): 2SS-267.
  • 3Boodhwani M, Voisine P, Ruel M, et al. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction[J]. Eur J Cardiothorac Surg, 2008, 33 (4): 645-650.
  • 4Gyongyosi M, Dib N. Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease[J]. Nat Rev Cardiol, 2011, 8(7): 393-404.
  • 5Stachowiak JC, von Muhlen MG, Li TH, et al. Piezoelectric control of needle-free transdermal drug delivery[J]. J Control Kelease, 2007, 124(1/2): 88-97.
  • 6Wagner S, Dues Gj Sawitzky D, et al. Assessment of the biological performance of the needle-free injector INJEX using the isolated porcine forelimb[J]. BrJ Dermatol, 2004, 150(3): 455-461.
  • 7Smith SC Jr, Mlen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and otheratherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute[J]. Circulation, 2006, 113(19): 2363-2372.
  • 8Mingliang R, Bo Z, Zhengguo W. Stem cells for cardiac repair: status, mechanisms, and new strategies[J]. Stem Cells Int, 2011: 310928.
  • 9Strauer BE, Schannwell CM, Brehm M. Therapeutic potentials of stem cells in cardiac diseases[J]. Minerva Cardioangiol, 2009, 57(2): 249-267.
  • 10Fishbein I, Chorny M, Levy RJ. Site-specific gene therapy for cardiovascular disease[J]. Curr Opin Drug Discov Devel, 2010, 13(2): 203-213.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部